Blood Transfusion
91
5
7
65
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Research Maturity
65 completed trials (71% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.2%
2 terminated out of 91 trials
97.0%
+10.5% vs benchmark
10%
9 trials in Phase 3/4
9%
6 of 65 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 65 completed trials
Clinical Trials (91)
Oxygen Extraction-guided Transfusion
Personalized Blood Transfusion Protocol for Cardiac Patients
Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya
Trends in Transfusion Strategies and Outcomes in Trauma
Prospective Investigation of Intra-Articular Tranexamic Acid Use in Elective Hip Arthroplasty
Donor Lifestyle and Nutritional Status, Blood Component Quality, and Patient Safety (ESENCIA)
Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants
Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery
Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs
Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients
Hemoglobin Levels for Blood Transfusions During and After Surgery
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections
Ostene in Thoracolumbar Decompression and Fusion Evaluated With VIBE
Full Assessment of Clinical Transfusion Support
Cell Salvage During Caesarean Section (CSCS)
Predicting CSA-AKI With ACTA-PORT Score
Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients
Management of Shock in Children With SAM or Severe Underweight and Diarrhea
Oral Versus Intravenous Tranexamic Acid
Decreased Consumption of Blood Components During Cardiac Surgery Procedures: Causes and Effects.